Skip to main content
Equibles

Sylvia

Analyst

JPMorgan

Equibles does not estimate personal net worth.

About Sylvia

Sylvia is recorded as Analyst at JPMorgan. Sylvia has spoken on 1 investor event across 1 company, most recently for Aktis Oncology, Inc. on May 5, 2026. The companies whose calls Sylvia spoke on are classified in the Healthcare sector.

Sylvia on recent calls

“You're going into both Pervicto Naive and experienced patients here. For the patients who are Pervicto Naive, can you speak with a bit more detail to the profile of patient you anticipate enrolling?”
Analyst — JPMorgan, AKY-2519 Clinical Development Strategy Conference Call ·

Affiliation history

  • JPMorgan

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity